UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.95 -0.05 (-0.06%) GOLD FUTURES
2,311.30 +0.30 (+0.01%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,349.73 +2,112.95 (+4.67%)
SRPT Jan 2026 210.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:23AM EDT. Market open.
| Previous close | 14.00 |
| Open | 14.00 |
| Bid | 13.00 |
| Ask | 15.50 |
| Strike | 210.00 |
| Expiry date | 2026-01-16 |
| Day's range | 14.00 - 14.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
Insider MonkeySarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript May 1, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.